Clinical Trial Update: Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether tacrolimus during liver transplant implantation reduces ischemia-reperfusion injury. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Medical University of Vienna | Conditions: Ischemia Reperfusion Injury | Phase 4 | Status: COMPLETED